Target intelligence / Profile preview

5S ribosomal RNA pseudogene 208 (RNA5SP208)

Target
RNA5SP208
Molecular classification
Pseudogene, rRNA pseudogene, Non-coding RNA pseudogene
01

Overview

5S ribosomal RNA pseudogene 208 (RNA5SP208) is a processed pseudogene derived from the 5S ribosomal RNA gene family[3][2]. Pseudogenes such as RNA5SP208 are segments of DNA that resemble functional genes but are generally nonfunctional, as they usually do not encode a functional RNA or protein product. 5S ribosomal RNA itself is a well-characterized structural component of the large ribosomal subunit, crucial for ribosome architecture and indirectly supporting protein synthesis[1][5]. However, pseudogenes like RNA5SP208 lack the necessary sequences for biological activity or participation in normal ribosome function.\nPseudogenes may occasionally have regulatory effects on gene expression (for example, acting as competing endogenous RNAs or influencing the regulation of their parent gene through RNA-mediated mechanisms), and their expression patterns have sometimes been implicated in cancer subgroup stratification in large-scale genomics studies[4]. However, there is no evidence that RNA5SP208 encodes a protein or functions as a therapeutic target, receptor, or biomarker, and it is not a drug-interacted molecule.\n\nKey points:\n- Pseudogenes are typically excluded from lists of valid therapeutic targets because they are generally nonfunctional genetic remnants[2][3].\n- There is no evidence for any druggability or role in disease etiology for RNA5SP208.\n- The target name is correct for a pseudogene, but as a pseudogene it does not fit the class of proteins or RNAs that are conventional molecular targets or receptors.\n- RNA5SP208 may occasionally be included as a feature in computational studies of cancer based on global expression profiling, but this does not confer a direct functional or druggable role[4].

Other names
RN5S208RNA5S ribosomal 208RNA5SP208
02

Disease associations

Other (pseudogenes can be used in cancer subtype analysis, but not as direct disease drivers)

Beyond the preview

Go deeper on 5S ribosomal RNA pseudogene 208 (RNA5SP208).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5S ribosomal RNA pseudogene 208 (RNA5SP208).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call